Lambiase, PD;
(2018)
AF stroke risk stratification-can we do better?
[Editorial comment].
International Journal of Cardiology
, 257
pp. 108-109.
10.1016/j.ijcard.2018.01.020.
Preview |
Text
Lambiase_IJC Editorial AF Risk Factor Scoring no Title page.pdf - Accepted Version Download (349kB) | Preview |
Abstract
We are now transitioning into the era of personalised tailored therapy with the application of risk stratification schemes based on easily measured clinical markers beautifully illustrated in determining the risk:benefit of anticoagulation in AF patients. The evolution of the CHADS score to CHA2DS2-VASc has refined therapeutic risk assessment coupled with the HASBLED score to assess bleeding risk. However, despite their apparent simplicity to ensure their utility, these scoring systems paper over a number of cracks in our knowledge base as reviewed in the paper by Professor Lip's group.
| Type: | Article |
|---|---|
| Title: | AF stroke risk stratification-can we do better? |
| Location: | Netherlands |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1016/j.ijcard.2018.01.020 |
| Publisher version: | https://doi.org/10.1016/j.ijcard.2018.01.020 |
| Language: | English |
| Additional information: | This version is the version of record. For information on re-use, please refer to the publisher’s terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science > Clinical Science |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10045591 |
Archive Staff Only
 |
View Item |
